Normal Function
The TECPR2 gene provides instructions for making a protein that is involved in a cellular process called autophagy. Cells use this process to recycle worn-out or unnecessary cell parts and break down certain proteins when they are no longer needed. During autophagy, materials that are no longer needed are isolated in compartments called autophagosomes. The autophagosomes are then transported to cell structures that break the materials down. The TECPR2 protein is thought to be important for the formation of autophagosomes.
Health Conditions Related to Genetic Changes
Spastic paraplegia type 49
At least five mutations in the TECPR2 gene have been found to cause spastic paraplegia type 49. This condition is characterized by gradually worsening muscle stiffness (spasticity) and paralysis in the lower limbs (paraplegia), intellectual disability, and other neurological problems that lead to trouble regulating involuntary body processes, such as digestion and breathing. Many of the mutations that cause spastic paraplegia type 49 change single protein building blocks (amino acids) in the TECPR2 protein. Others lead to production of an abnormally short protein that is likely broken down quickly. Alteration or loss of the TECPR2 protein is thought to impair autophagy, making cells less efficient at removing unneeded materials. Researchers suggest that nerve cells (neurons) may be particularly vulnerable to impaired autophagy because it is especially difficult to transport waste materials through their long extensions (axons and dendrites) for breakdown. The waste materials can build up in neurons and damage them. Damage to neurons results in the neurological problems that occur in spastic paraplegia type 49.
More About This Health ConditionOther Names for This Gene
- KIAA0329
- SPG49
- tectonin beta-propeller repeat-containing protein 2 isoform 1
- tectonin beta-propeller repeat-containing protein 2 isoform 2
Additional Information & Resources
Tests Listed in the Genetic Testing Registry
Scientific Articles on PubMed
Catalog of Genes and Diseases from OMIM
References
- Covone AE, Fiorillo C, Acquaviva M, Trucco F, Morana G, Ravazzolo R, Minetti C. WES in a family trio suggests involvement of TECPR2 in a complex form of progressive motor neuron disease. Clin Genet. 2016 Aug;90(2):182-5. doi: 10.1111/cge.12730. Epub 2016 Feb 10. Citation on PubMed
- Heimer G, Oz-Levi D, Eyal E, Edvardson S, Nissenkorn A, Ruzzo EK, Szeinberg A, Maayan C, Mai-Zahav M, Efrati O, Pras E, Reznik-Wolf H, Lancet D, Goldstein DB, Anikster Y, Shalev SA, Elpeleg O, Ben Zeev B. TECPR2 mutations cause a new subtype of familial dysautonomia like hereditary sensory autonomic neuropathy with intellectual disability. Eur J Paediatr Neurol. 2016 Jan;20(1):69-79. doi: 10.1016/j.ejpn.2015.10.003. Epub 2015 Oct 22. Citation on PubMed
- Oz-Levi D, Ben-Zeev B, Ruzzo EK, Hitomi Y, Gelman A, Pelak K, Anikster Y, Reznik-Wolf H, Bar-Joseph I, Olender T, Alkelai A, Weiss M, Ben-Asher E, Ge D, Shianna KV, Elazar Z, Goldstein DB, Pras E, Lancet D. Mutation in TECPR2 reveals a role for autophagy in hereditary spastic paraparesis. Am J Hum Genet. 2012 Dec 7;91(6):1065-72. doi: 10.1016/j.ajhg.2012.09.015. Epub 2012 Nov 21. Citation on PubMed or Free article on PubMed Central
- Stadel D, Millarte V, Tillmann KD, Huber J, Tamin-Yecheskel BC, Akutsu M, Demishtein A, Ben-Zeev B, Anikster Y, Perez F, Dotsch V, Elazar Z, Rogov V, Farhan H, Behrends C. TECPR2 Cooperates with LC3C to Regulate COPII-Dependent ER Export. Mol Cell. 2015 Oct 1;60(1):89-104. doi: 10.1016/j.molcel.2015.09.010. Citation on PubMed
The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.